Hikma Pharmaceuticals Usa Inc. 401(K) Retirement Plan — Form 5500 plan (Hikma Pharmaceuticals Usa Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Hikma Pharmaceuticals Usa Inc. 401(K) Retirement Plan is a benefit plan reported by Hikma Pharmaceuticals Usa Inc. under EIN 22-3114571 and plan number 002. The latest loaded filing year is 2023. The filing reports 2,525 participants and $244,033,128 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Hikma Pharmaceuticals Usa Inc.
EIN
22-3114571
Plan number
002
Plan type
2
Location
Berkeley Heights, NJ
Latest filing year
2023
Participants
2,525
End-of-year plan assets
$244,033,128

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20232,525H, C20241011141022NAL0011002275001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$244,033,128
Total liabilities (EOY)
$0
Net assets (EOY)
$244,033,128
Net assets (BOY)
$212,785,122

Income & contributions

Employer contributions
$9,133,767
Participant contributions
$14,524,690
Total contributions
$26,501,236
Total income / additions
$56,941,185

Expenses & distributions

Benefits paid
$25,415,498
Administrative expenses
$273,248
Total expenses
$25,693,179
Net increase / (decrease)
$31,248,006

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Merrill Lynch, Pierce, Fenner And SRECORDKEEPER$272,459$02023

Related Form 5500 pages